122 related articles for article (PubMed ID: 32397747)
1. A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer.
Wang H; Xu F; Zhang M; Liu J; Wang F; Zhao Q
DNA Cell Biol; 2020 Jul; 39(7):1181-1193. PubMed ID: 32397747
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
4. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.
Zhao X; Liu J; Liu S; Yang F; Chen E
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689990
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles for a prognostic immunoscore in gastric cancer.
Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
[TBL] [Abstract][Full Text] [Related]
7. An immune infiltration signature to predict the overall survival of patients with colon cancer.
Peng D; Wang L; Li H; Cai C; Tan Y; Xu B; Le H
IUBMB Life; 2019 Nov; 71(11):1760-1770. PubMed ID: 31301220
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles for an immunoscore model in bone and soft tissue sarcoma.
Fan J; Qin X; He R; Ma J; Wei Q
Aging (Albany NY); 2021 May; 13(10):13708-13725. PubMed ID: 33946044
[TBL] [Abstract][Full Text] [Related]
9. An immunoscore nomogram for predicting survival in patients with oesophageal cancer.
Li G; Song Q; Cai A; Wei Z; Zhang R; Yi D; Chen J; Li F; Zhang Y; Liu L; Wu Y; Yi D
Aging (Albany NY); 2021 Mar; 13(6):8762-8776. PubMed ID: 33714960
[TBL] [Abstract][Full Text] [Related]
10. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Bai J; Zhang X; Xiang ZX; Zhong PY; Xiong B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1134-1141. PubMed ID: 32096169
[TBL] [Abstract][Full Text] [Related]
12. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer.
Zhang B; Wang L; Liu Z; Shao B; Jiang W; Shu P
Medicine (Baltimore); 2020 Jun; 99(25):e20617. PubMed ID: 32569190
[TBL] [Abstract][Full Text] [Related]
14. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
15. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform.
Tang X; Xu P; Chen A; Deng G; Zhang S; Gao L; Dai L; Chen Q
Front Genet; 2020; 11():514363. PubMed ID: 33244317
[TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
20. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
